About P&T JournalContacts:
Statement of Purpose
Guidelines for Authors
Erlotinib (Tarceva) for patients with pancreatic cancer; nelarabine (Arranon) injection for leukemia and lymphoma; and sodium oxybate oral solution (Xyrem) for the treatment of narcolepsy are highlighted.
Marvin M. Goldenberg, PhD, RPh, MS
Dr. Wittbrodt emphasizes the urgent need for effective therapies for prolonged postoperative ileus, which is often associated with increased hospital costs and an extended length of stay for patients.
Eric Wittbrodt, PharmD, BCPS
The Prescotts report on the use of extended-release niacin for dyslipidemic patients with HIV infection, a lipid-lowering combination of fenofibrate/ezetimibe for mixed hyperlipidemia, omega-3 fatty acids for overweight children, low-dose pravastatin for mild hypercholesterolemia, a strategy for women with acute coronary syndrome, low-molecular-weight heparin for ST-segment elevation myocardial infarction (MI), pioglitazone for diabetic patients with previous MIs, and nesiritide and levosimendan (Simdax) for decompensated heart failure.
Lawrence M. Prescott, PhD, and Sharon L. Prescott
Advances in treating autism; Alzheimer’s disease; substance abuse; and movement disorders, including Huntington’s disease and Parkinson’s disease, by means of viral vector techniques, are presented.
This month, three of P&T’s editorial board members contribute reviews of books of interest to the health care community: Handbook of Clinically Tested Herbal Remedies, Volumes 1 and 2, by Marilyn Barrett, PhD, Editor, reviewed by Robert L. Barkin, MBA, PharmD; Dictionary of Pharmacy, by Dennis B. Worthen, PhD, Editor-in-Chief, reviewed by F. Randy Vogenberg, RPh, PhD; and Flashback by Gary Braver, reviewed by Art Shinn, PharmD.
David Nash, MD, MBA, discusses the potential of a new electronic database that would automatically monitor the safety and efficacy of drugs used under the Medicare Part D Prescription Drug Plan.
David Nash, MD, MBA
Medicaid Reforms Spark Opposition: Congress Rejects Tiered Formularies But Approves Alternative Benefit Packages
Stephen Barlas discusses the “reconciliation bill” recently debated in Congress and the controversy over co-pays, tiered formularies, and
Involving Nonclinical Departments in Patient Safety Discussions Can Reduce the Risk of Serious Errors
Matthew Grissinger, RPh, FASCP, suggests ways to involve non-clinical staff members, in addition to clinicians, in preventing errors that can occur when non-drug items are repackaged into empty containers.
Matthew Grissinger, RPh, FASCP
P&T presents the latest information about FDA approvals, drug indications, and new devices.
Tigecycline (Tygacil): A Novel First-in-Class, Broad-Spectrum Intravenous Antibiotic For the Treatment of Serious Bacterial Infections
Tigecycline (Tygacil), a broad-spectrum intravenous antibiotic for bacterial infections, is featured.
Robert Harris, PharmD Candidate, and Martin Cruz, PharmD, CGP